|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 323/52 | |
| A61K 31/215 | |||
| A61P 17/00 | |||
| A61P 31/00 |
| (11) | Number of the document | 2576505 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11724938.3 |
| Date of filing the European patent application | 2011-05-23 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AT2011/000237 |
| Date | 2011-05-23 |
| (87) | Number | WO 2011/146954 |
| Date | 2011-12-01 |
| (30) | Number | Date | Country code |
| 10450092 | 2010-05-26 | EP |
| (72) |
RIEDL, Rosemarie, AT
HEILMAYER, Werner, AT
SPENCE, Lee, AT
|
| (73) |
Nabriva Therapeutics GmbH,
Leberstrasse 20, 1110 Wien,
AT
|
| (54) | CRYSTALLINE FORM OF A PLEUROMUTILIN |
| CRYSTALLINE FORM OF A PLEUROMUTILIN |